Search company, investor...

Total Raised

$49.02M

Investors Count

6

Deal Terms

3

Funding, Valuation & Revenue

6 Fundings

Cardeas Pharma has raised $49.02M over 6 rounds.

Cardeas Pharma's latest funding round was a Series B - II for $3.5M on April 9, 2015.

Cardeas Pharma's valuation in June 2012 was $24.18M.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

4/9/2015

Series B - II

$3.5M

$99M

0

FY undefined

1

5/23/2013

Series B

$99M

$99M

0

FY undefined

10

9/28/2012

Series A - II

$99M

$99M

0

FY undefined

0

6/7/2012

Series A

$99M

$24.18M

0

FY undefined

0

2/10/2011

Seed

$99M

$99M

0

FY undefined

10

Date

4/9/2015

5/23/2013

9/28/2012

6/7/2012

2/10/2011

Round

Series B - II

Series B

Series A - II

Series A

Seed

Amount

$3.5M

$99M

$99M

$99M

$99M

Investors

Valuation

$99M

$99M

$99M

$24.18M

$99M

Revenue

0

FY undefined

0

FY undefined

0

FY undefined

0

FY undefined

0

FY undefined

Sources

1

10

0

0

10

You're one click away from the most comprehensive, unmatched analyst expertise in tech, in-depth private company data and a platform that brings it all together.
Click Now. Join a live demo
Join a demo
CB Insights
Looking for a leg up on competitive, customer and technology insights?
CB Insights puts confidence and clarity into your most strategic decisions.
See how. Join a demo.
Join a demo
Trusted by the world's smartest companies to:
  • Predict emerging trends
  • See competitors' playbooks
  • Stalk the smart money
  • Identify tomorrow's challengers
  • Spot growing industries
  • Kill analyst data work
Let's see how we can help you!
MicrosoftWalmartWells Fargo

Cardeas Pharma Deal Terms

3 Deal Terms

Cardeas Pharma's deal structure is available for 3 funding rounds, including their Series B - II from April 09, 2015.

Round

Series B - II

Series B

Series A

Funding Date

$99M

$99M

$99M

Pre-Money Valuation

Post-Money Valuation

Amount Raised

$99M

$99M

$99M

Shares Authorized

Issuance Price

$99M

$99M

Dividend Rate

$99M

$99M

Liquidation Preferences

$99M

$99M

Liquidation Price

Participation

Conversion Price

Anti Dilution

$99M

$99M

General Voting

$99M

$99M

$99M

Board Voting

$99M

$99M

$99M

Par Value

Round

Funding Date

Pre-Money Valuation

Post-Money Valuation

Amount Raised

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

Board Voting

Par Value

Series B - II

$99M

$99M

$99M

$99M

$99M

$99M

$99M

$99M

Series B

$99M

$99M

$99M

$99M

$99M

$99M

$99M

$99M

Series A

$99M

$99M

$99M

$99M

Cardeas Pharma Investors

6 Investors

Cardeas Pharma has 6 investors. Avalon Ventures invested in Cardeas Pharma's Series B - II funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

6/7/2012

4/9/2015

4
Series A, Series A - II (2012), Series B (2013), Series B - II (2015)

Venture Capital

California

00/00/0000

00/00/0000

Novo Holdings

Subscribe to see more

Holding Company

Denmark

00/00/0000

00/00/0000

Devon Park Bioventures

Subscribe to see more

Venture Capital

Pennsylvania

00/00/0000

00/00/0000

Delphi Ventures

Subscribe to see more

Venture Capital

California

00/00/0000

00/00/0000

H.I.G. BioHealth Partners

Subscribe to see more

Venture Capital

Florida

First funding

6/7/2012

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Last Funding

4/9/2015

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Investor

Novo Holdings

Devon Park Bioventures

Delphi Ventures

H.I.G. BioHealth Partners

Rounds

4
Series A, Series A - II (2012), Series B (2013), Series B - II (2015)

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Board Seats

Type

Venture Capital

Holding Company

Venture Capital

Venture Capital

Venture Capital

Location

California

Denmark

Pennsylvania

California

Florida

CB Insights
Looking for a leg up on competitive, customer and technology insights?
CB Insights puts confidence and clarity into your most strategic decisions.
See how. Join a demo.
Join a demo
Trusted by the world's smartest companies to:
  • Predict emerging trends
  • See competitors' playbooks
  • Stalk the smart money
  • Identify tomorrow's challengers
  • Spot growing industries
  • Kill analyst data work
Let's see how we can help you!
MicrosoftWalmartWells Fargo

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.